突触囊糖蛋白2C:在帕金森病中发挥作用
Chu Hua Chang1,2, Kah Leong Lim1,3, Jia Nee Foo1,4
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Frontiers in cellular neuroscience
|September 20, 2024
概括
突触膀糖蛋白2C (SV2C) 是帕金森病 (PD) 的新型风险因素. 本综述探讨了SV2C在PD病变发生中的作用及其作为这种神经退行性疾病治疗点的潜力.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学是一种遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,影响全球数百万人.
- 突触囊糖蛋白2C (SV2C) 在中脑等大脑区域具有选择性表达.
- SV2C正在成为PD的重要因素.
研究的目的:
- 巩固有关SV2C功能及其在PD中的作用的当前知识.
- 评估SV2C作为帕金森病的潜在治疗点.
- 探索将SV2C与PD病变发生联系的途径.
主要方法:
- 综合遗传学和分子研究的文献综述.
- 对东亚最大的PD全基因组关联研究结果的分析.
- 探索SV2C对突触囊泡贩运和神经递质释放的影响.
主要成果:
- SV2C已被确定为帕金森病的新型风险因素.
- SV2C在突触囊泡贩运和神经递质释放中发挥作用.
- 在SV2C的作用下,SV2C会影响α-synuclein的恒温.
结论:
- SV2C是帕金森病的一个有前途的治疗点.
- 对SV2C通路的进一步研究可能会导致新的PD治疗方法.
- 了解SV2C的作用对于对抗PD至关重要.
相关概念视频
Parkinson's Disease: Overview
495
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment
235
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Overview of Secretory Vesicles
8.5K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.5K
Fusion of Secretory Vesicles with the Plasma Membrane
11.0K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
11.0K


